We are delighted to welcome you to the 1st International Conference of Classical Hematology 2026 — a landmark gathering dedicated to showcasing the latest advancements, research, and innovations shaping the field of Hematology.

Join us for a dynamic and insightful scientific program designed to foster collaboration, inspire discovery, and advance excellence in Hematology practice and research.

Session highlights at a glance

Advances in the Diagnosis and Management of Hemolytic Anemias
Thalassemia Management
Hemophagocytic Lymphohistiocytosis
Thrombosis
Latest Management on Hemophilia
Updates on ITP
Paroxysmal Nocturnal Hemoglobinuria 
Updates on TTP
Sickle Cell Management

View Program

CME Accreditation

Instructions for Claiming CME Certificates:

Post the event, registered attendees will receive an online evaluation survey to their registered email address.
Once the survey is completed, you will automatically receive the CME Certificate by email.
Please ensure that the email address provided at the time of registration is accurate.

Disclosure and Resolution of Personal Conflicts of Interest

This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support.

Session Attendance Scanning :

Attendance to the sessions will be monitored through scanning of the barcode on your conference badge at the entrance of the session hall.
CME credits will be awarded in accordance with session attendance.

We are proud to present the distinguished speakers and faculty of the 1st International Conference of Classical Hematology (ICCH) 2026. This accomplished group of experts will share their insights and perspectives, shaping ICCH 2026 into an unmissable event for professionals committed to advancing hematology.

The conference features renowned leaders from leading institutions around the world, delivering a scientific program designed to inspire innovation, enhance learning, and drive meaningful progress in hematology.

Abdulhakim Al Rawas

President, Omani Society of Hematology Senior Consultant, Pediatric Hematology/Oncology

Sultan Qaboos University Hospital Oman

Oman

Bio

Dr. Abdulhakim Al-Rawas is a Senior Consultant in Pediatric Hematology/Oncology at Sultan Qaboos University Hospital and President of the Omani Society of Hematology. A founding leader in regional hematology organizations, he trained at Queen’s University and SickKids, Toronto. He is deeply involved in undergraduate and postgraduate medical education in Oman and has authored 33 peer-reviewed publications in pediatric hematology and oncology.

Abdullah Al Zayed

Consultant Hematologist and Former Head of the Inherited Blood Disorders Center

Qatif Health Network

Saudi Arabia

Bio

Dr. Abdullah Al Zayed is a consultant hematologist and is the former head of the inherited blood disorders center at Qatif Central Hospital, He is the founder and first program director of hematology fellowship at Qatif Health Network. He championed the sickle cell disease pathway in the eastern health cluster for adult patients. He was trained in Ireland and gained the MRCPI & Hematology fellowship by RCPI. He is the hematology service leader & the manager of the hematology program in the Eastern cluster of the Ministry of Health- Hematology Development program project.

Abdulrahman Al-Mashdali

Hematologist

Hamad Medical Corporation

Qatar

Bio

Dr. Abdulrahman Al-Mashdali is a hematology fellow at the National Center for Cancer Care and Research (NCCCR), Qatar. He holds MRCP and Arab and Qatari Board certifications in Internal Medicine from Hamad Medical Corporation. His clinical interests include malignant and benign hematology. He has a strong research portfolio with approximately 100 publications and abstracts, and has presented at major international conferences, including ASH, EHA, and SOHO.

Afaf Al Battah

Consultant Hematologist

NCCCR- Hamad Medical Corporation

Qatar

Bio

Dr. Afaf Al Battah is a Consultant Hematologist who graduated with an MBBS from the University of Jordan. She completed her internship and Internal Medicine residency at Hamad General Hospital in 2006, followed by a fellowship in Clinical Hematology at NCCCR. Dr. Al Battah has a special clinical interest in lymphoma and lymphoid malignancies and is dedicated to delivering high-quality, patient-centered hematology care.

Ahmad Tarawah

President, Madinah Hereditary Blood Disorders Society

President, Middle East and North Africa Hematology League

Saudi Arabia

Bio

Professor Ahmad M. Tarawah is a pediatric hematologist and oncologist based in Madinah, Saudi Arabia. He serves as a consultant at King Salman Medical City and chairs the Madinah Hereditary Blood Disorders Society. Holding a medical degree from King Abdulaziz University (1990), he completed pediatric training in Edinburgh and earned his Arab Board certification in 1997. He further specialized in pediatric hematology/oncology at King Faisal Specialist Hospital, obtaining a fellowship in 2001. Professor Tarawah has authored over 140 publications, contributed to national treatment guidelines, and founded multiple hematology societies and charitable organizations. His work focuses on hemophilia, sickle cell anemia, and bleeding disorders.

Ali Taher

Professor of Medicine in Hematology & Oncology at the American University of Beirut Medical Center

Director of Naef K. Basile Cancer Institute, and Associate VP for Academic Centers

Lebanon

Bio

Ali T. Taher, MD, PhD, FRCP is Professor of Medicine at the American University of Beirut (AUB), Director of the Naef K. Basile Cancer Institute, and Associate Vice President for Academic Centers and External Affairs. He is an internationally recognized leader in thalassemia and iron metabolism, with major contributions to prevention and clinical care in Lebanon and beyond. Dr. Taher has authored more than 540 peer-reviewed publications (h-index 84; over 32,000 citations) and has led landmark international clinical trials, including a Phase 3 study of oral mitapivat published in The Lancet. His achievements have been recognized with numerous prestigious awards, including the National Cedar Medal of Lebanon, the Sultan Bin Khalifa International Thalassemia Award, and the EHA Education and Mentoring Award. He currently chairs the EHA Scientific Working Group on Red Cells and Iron and serves on scientific committees of the American Society of Hematology (ASH).

Asma Sultan Al Olama

President, Emirates Society of Haematology

Consultant Hematologist, Dubai Hospital

United Arab Emirates

Bio

Dr. Asma Al Olama is the President of the Emirates Society of Haematology and a Consultant Hematologist at Dubai Hospital. She has been actively involved in the field of hematology, particularly in the UAE, and has contributed to various initiatives and best practices in the area. Additionally, she serves as the Program Director of the Adult Hematology Fellowship program at Dubai Health.

Awni Alshurfa

Hematology specialist, National Center for Cancer Care & Research

Hamad Medical Corporation

Qatar

Bio

Dr. Awni Alshurafa is a Hematology specialist at the National Center for Cancer Care & Research (NCCCR). He graduated from medical school with a Bachelor of Medicine from the Islamic University of Gaza in Palestine. Subsequently, he completed his Internal Medicine residency and Hematology Fellowship training at Hamad Medical Corporation in Qatar. He is certified by the Arab Board in Internal Medicine and obtained certification from the European Hematology Association (EHA) in 2023. Dr. Awni is actively engaged in research and has several publications including blood journals and international conferences like EHA and ASH.

Biree Andemariam

Professor of Medicine and the American Red Cross Endowed Chair in Transfusion Medicine

University of Connecticut School of Medicine

United States

Bio

Biree Andemariam, M.D. is Professor of Medicine and the American Red Cross Endowed Chair in Transfusion Medicine at the University of Connecticut School of Medicine. In addition to being an internationally recognized clinician, educator, and advocate, she is a physician scientist in the Division of Hematology/Oncology, Founding Director of the New England Sickle Cell Institute (NESCI), and Director of the Connecticut Bleeding Disorders Center. Dr. Andemariam has been lead principal investigator of 5 global SCD clinical trials and has extensive experience in clinical trial design, endpoint development, recruitment, and implementation. She also expertise in working with executive leadership, regulatory, and investor teams. During the COVID-19 global crisis, she mobilized and chaired an international committee of experts in the development and worldwide dissemination of guidelines on managing patients with SCD during the pandemic. Dr. Andemariam is the past Chief Medical Officer of the Sickle Cell Disease Association of America, Inc. During her tenure at the SCDAA, she was awarded the Chairman’s Award three times (2019, 2020, 2022) for her outstanding and dedicated board service centered around national programmatic development, disease education/awareness, and legislative advocacy. She is a member of the 2023 Lancet Commission, a global group of experts selected to develop and publish a set of recommendations to achieve greater political commitment, investment, and partnerships to improve the lives of patients with sickle cell disease globally by 2040.

Caterina Minniti

Professor Emeritus of Medicine and Pediatrics

Albert Einstein College of Medicine

United States

Bio

Dr. Minniti is a board-certified Pediatric Hematologist–Oncologist and Professor Emeritus of Medicine and Pediatrics at Albert Einstein College of Medicine, New York. Former Director of major sickle cell centers in New York and Washington, DC, she trained in Italy and the USA at Johns Hopkins, NIH, NCI, and NHLBI. A leading clinical trialist and translational researcher in sickle cell disease, she has authored 170+ peer-reviewed publications and book chapters.

David Kuter

Professor of Medicine at Harvard Medical School

Distinguished Physician at Massachusetts General Hospital

United States

Bio

Prof. David Kuter is Distinguished Physician at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. A former Chief of Hematology at MGH, he is a global leader in thrombopoietin biology and immune thrombocytopenia. A Rhodes Scholar, he has authored over 350 publications, delivered 700+ international lectures, and received numerous prestigious teaching and research awards in hematology.

Drew Provan

Emeritus Reader in Autoimmune Haematology

Barts and The London School of Medicine and Dentistry

United Kingdom

Bio

Dr. Drew Provan is Emeritus Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry. He originally studied molecular genetics before training in medicine, and later undertook research at the Dana–Farber Cancer Institute in Boston as an MRC Travelling Fellow. Dr Provan is a leading authority in immunohaematology, with a major focus on immune thrombocytopenia, neutropenia and haemolytic anaemia. He helped establish the UK ITP Registry and is a senior author of the International Consensus Guidelines for the diagnosis and management of ITP in adults and children. He has published extensively in the field and is author of several well-known medical texts, including Molecular Haematology, the Oxford Handbook of Clinical Haematology, and the ABC of Clinical Haematology.

Flora Peyvandi

Director of the Department of Pathophysiology and Transplantation

Director of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center

Italy

Bio

Dr. Flora Peyvandi is Professor of Internal Medicine at the University of Milan and Director of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center at Milan Policlinic Hospital, Italy. Her research focuses on coagulation disorders, microvascular dysfunction, and innovative diagnostic and therapeutic strategies. She has held leading roles in international scientific societies, including President of the International Society on Thrombosis and Haemostasis, and currently serves as an advisor to the European Medicines Agency and the Italian Ministry of Health.

Gerry Dolan

Consultant Haematologist and Hemophilia Centre Director

St Thomas’ Comprehensive Care Centre

United Kingdom

Bio

Dr. Gerry Dolan is a consultant haematologist and haemophilia centre director at St Thomas’ Comprehensive Care Centre, London, UK, and former centre director at Nottingham University Hospitals, Nottingham, UK. He is former chairman of the UK Haemophilia Centre Directors and president of the British Society for Haemostasis & Thrombosis. He has been an active participant in collaborative European initiatives in haemophilia and has chaired initiatives such as the ADVANCE group and the European Haemophilia Therapy Standardisation Board. His interests include novel agents in the treatment of haemophilia, gene therapy and clinical outcomes.

Hadeel Saleh

Consultant in Pediatric Hematology, Oncology, Hemostasis, and Thrombosis

NBK Specialized Children’s Hospital

Kuwait

Bio

Dr. Hadeel Saleh Mohammad is a Consultant in Pediatric Hematology, Oncology, Hemostasis, and Thrombosis at NBK Specialized Children’s Hospital, Kuwait. She completed the Kuwaiti Board in Pediatrics and fellowships in Pediatric Hematology/Oncology and Hemostasis and Thrombosis at McMaster University, Canada. She has published and presented research on bleeding disorders and currently serves as President of the Kuwait Hematology Association.

Hani Osman

Medicine Hematology Oncology, Consultant Physician

Tawam Hospital

United Arab Emirates

Bio

Dr. Hani Yousif Osman graduated from the Faculty of the Medicine University of Khartoum Sudan. He moved to the United Kingdom where he completed his training in internal medicine and obtained his MRCP (UK) degree, Fellowship from the Royal college of pathologists and CCT. He completed his high specialist training in hematology at the University of Cardiff hospital UK. His research focuses on acute myeloid leukemia novel therapy, He has extensive hematology consultant experience in the UK, Saudia Arabia, and the United Arab Emirates. Dr. Osman was involved and the principle investigator for many clinical trials and he has over 30 publications.

Hanny Al- Samkari

Associate Professor of Medicine, Harvard Medical School

The Peggy S. Blitz Endowed Chair in Hematology/Oncology, Massachusetts General Hospital

United States

Bio

Hanny Al-Samkari, M.D. is a classical hematologist and leading international clinical investigator in hemostasis, platelet disorders, and hemolytic anemias. His focus is on the development of novel therapeutics in hereditary hemorrhagic telangiectasia, immune thrombocytopenia, chemotherapy-induced thrombocytopenia and hemolytic anemia. He serves as global principal investigator for many ongoing studies in these areas.

Hind Salama

Consultant Adult Hematology

King Abdullah Medical City - KAMC

Saudi Arabia

Bio

Dr. Hind Salama is a Consultant Adult Hematologist at King Abdulaziz Medical City, Riyadh, and Assistant Professor at King Saud bin Abdulaziz University for Health Sciences. She holds an MBBS from Gezira University and MRCP (UK), with fellowship training in hematology and bone marrow transplantation. She leads adult acute lymphoblastic leukemia and histiocytic clinics and established Saudi Arabia’s first adult histiocytic clinic. Dr. Salama has received multiple research awards, authored 46 publications, and is an ASH Choosing Wisely Champion.

Honar Cherif

Senior Consultant Hematologist Chairman of Dept of Hematology & BMT National Center for Cancer Care & Research

Hamad Medical Corporation

Qatar

Bio

Dr. Honar Cherif is Professor and Senior Consultant Hematologist, currently Chair of Hematology and Bone Marrow Transplantation at NCCCR, Hamad Medical Corporation, Doha. He is Professor of Hematology at Qatar University and has extensive leadership experience in Sweden at Uppsala University Hospital. Board-certified in Hematology and Internal Medicine, Dr. Cherif has authored over 60 publications, led multiple clinical trials, and mentors students and specialists in hematology worldwide.

Jaffer Altooq

Chief Resident at the Hereditary Blood Disorder Centre

Salmaniya Medical Complex

Bahrain

Bio

Dr. Jaffer Abduljabbar Altooq is Chief Resident at the Hereditary Blood Disorder Centre, Salmaniya Medical Complex, Bahrain. He leads the Sickle Cell Disease team and serves on the SCD management board and MOH transfusion committee. With extensive experience in hematology and oncology, he coordinates training programs and has published research on sickle cell disease. He also volunteers as Deputy Chairman of the Bahrain Sickle Cell Society and with local charitable organizations.

Jan-Inge Henter

Professor, Senior

Karolinska Institutet

Sweden

Bio

Jan-Inge Henter earned an MD from Uppsala University 1980 and completed a fellowship in Pediatrics in 1987. In 1990, he defended a PhD-thesis with focus on HLH. Since 2004, he is Professor of Pediatrics at the Karolinska Institute. He was Principal Investigator of the HLH-94 and HLH-2004 studies, and he has also studied the underlying biology in HLH. He is also interested in Langerhans cell histiocytosis and End-of-Life Care, and has more than 250 publications. He was President of the Histiocyte Society 2004-2007. During 2012–2017 he was Director of Research and Education of the Karolinska University Hospital. He describes himself as a curious and enthusiastic explorer of the World, and everything in it!

Khaled Musallam

Group Chief Research Officer, Deputy CEO and Chief of C&G Therapy and Hematology, Burjeel Cancer Institute

Burjeel Medical City, Abu Dhabi

United Arab Emirates

Bio

Prof. Khaled Musallam MD PhD is currently the Group Chief Research Officer at Burjeel Holdings in Abu Dhabi, UAE where he founded the clinical research function and operations across the Group’s large hospital network. He is also Deputy CEO and Chief of Cell & Gene Therapy and Hematology, Director of the Thalassemia & Sickle Cell Center, and Founding Director of the Center for Research on Rare Blood Disorder (CR-RBD) at Burjeel Cancer Institute located in the Group’s flagship hospital, Burjeel Medical City. He is also Adjunct Professor at Khalifa University in Abu Dhabi and Adjunct Professor at Weill Cornel Medicine in New York. He has authored over 230 articles on hemoglobin disorders with practice-changing papers in leading international peer-reviewed journals including the New England Journal of Medicine, Lancet, Nature, Blood, among others. His h-index is 65. He is also editor of the Thalassaemia International Federation management guidelines. Prof. Musallam was the recipient of the 2025 European Haematology Association Clinical Excellence Award.

Lan-Lan Smith

Editor-in-Chief

The Lancet Haematology

United Kingdom

Bio

Dr Lan-Lan Smith is the founding Editor-in-Chief of The Lancet Haematology, launching the journal in 2014. She earned her PhD from Cancer Research UK/University College London, UK, in acute myeloid leukaemia genetics and held post-doctoral research posts in the Haemato-Oncology Section at the Institute of Cancer Research, UK, and in the Department of Haematology-Oncology at King's College London, London, UK, before joining The Lancet group as a Senior Editor at The Lancet Oncology in 2011.

Lulwah Altourah

Senior Specialist

Adan Hospital

Kuwait

Bio

Dr. Lulwah Faisal Al-Tourah is a board-certified hematologist at Al-Adan Hospital and the Kuwait Cancer Control Center. She completed specialized fellowships in thrombosis and bleeding disorders at McMaster University, Canada. Her clinical and academic interests focus on thrombosis, bleeding disorders, and cancer-associated thrombosis. She is committed to patient-centered care and advancing hematology through clinical practice, and education.

Maria Domenica Cappellini

Professor of Internal Medicine

University of Milan, Fondazione IRCCS Policlinico Hospital

Italy

Bio

Dr. Cappellini has been active in the fields of thalassaemia, haemoglobinopathies, and the heme biosynthetic pathway for over 40 years. She focused on the phenotypic expression of thalassaemia major and intermedia and evaluated the genotype-phenotype relationship, taking into account the co-inheritance of modifier genes. She identified the mechanisms underlying the thrombotic risks in thalassaemia. She studies in vitro molecules capable of inducing fetal hemoglobin in view of therapeutic application. She is involved in gene therapy development for thalassemia.

Mohamed Yassin

Senior Consultant Hematologist

Chairman - Hematology Academy

Qatar

Bio

Prof. Prof. Mohamed A. Yassin is a Senior Consultant Hematologist at the National Center for Cancer Care and Research, and Professor of Hematology at Qatar University. His key interests include myeloproliferative neoplasms, thalassemia, and sickle cell disease. He has led numerous international collaborations and clinical trials, focusing on cancer biomarkers and therapeutics, with research partnerships in France and Italy. Prof. Yassin remains deeply committed to advancing hematologic research in Qatar and beyond.

Mohsen Alzahrani

Consultant and section head Adult Stem Cell Transplant and Cellular Therapy

King Abdulaziz Medical City – Riyadh

Bio

No Bio Available

Mozah AlMarshoodi

Chair of Medical Institute

Sheikh Khalifa Hospital, Fujairah

United Arab Emirates

Bio

Dr. Mozah Obaid Almarshoodi is a Consultant in Benign Hematology and the Acting Head of Medical Department at Sheikh Khalifa Hospital Fujairah, specializing in blood disorders, including thrombosis, bleeding disorders, and hemoglobinopathies. She completed her Consultative Hematology Fellowship at the University of Toronto and is skilled in patient care, education, and clinical research. Fluent in Arabic and English, Dr. Almarshoodi is dedicated to improving hematology care and mentoring future medical professionals in the UAE.

Muna Al Rasheed

Consultant, Head of clinical hematology unit

Adan Hospital, MOH

Kuwait

Bio

Dr. Muna Al Rasheed is a consultant and head of clinical haematology unit adan hospital MOH kuwait. She is also the Head of examinations committee for clinical hematology fellowship KIMS , she is a Graduate of faculty of medicine kuwait university , done her Internship in internal medicine university of Toronto and has a Fellowship in clinical hematology McMaster university as well as a Number of publications in itp / ttp/ pnh and other benign hematology

Muna Al Tarshi

Senior Consultant - Hematology and Bone Marrow Transplant

The Royal Hospital

Oman

Bio

Dr. Muna Altarshi is a Senior Consultant at the Royal Hospital, Muscat. She earned her MD from Sultan Qaboos University and completed Internal Medicine and Hematology training at McGill University, obtaining FRCPC and American Board certifications. She completed a Bone Marrow Transplant fellowship at Princess Margaret Cancer Centre, University of Toronto. Her practice focuses on lymphoma, plasma cell myeloma, and autologous stem cell transplantation. She is Associate Program Director at the Oman Medical Specialty Board and Treasurer of the Omani Society of Hematology.

Namrata Singh

Founder & CEO

Turacoz Group

Bio

Dr Namrata is a distinguished pediatrician, medical writer, and visionary leader dedicated to transforming healthcare for children. As Founder & CEO of Turacoz Group, she bridges medical knowledge and effective communication, simplifying complex concepts for diverse audiences. A passionate mentor, she fosters growth and collaboration, while also promoting healthy lifestyles for young individuals. Known for her determination, excellence, and compassion, Dr Namrata inspires through her leadership and commitment to positive change.

Salam Al Kindi

Professor & Senior Consultant Hematologist, Director of National Hematology anc BMT center

University Medical City, Muscat

Oman

Bio

Professor Salam Alkindi is Professor and Senior Consultant in Hematology at Sultan Qaboos University, Muscat, and Director of the Hematology and Bone Marrow Transplant Center. Trained in Ireland and at Fred Hutchinson Cancer Center, USA, he has published over 140 peer-reviewed articles. His research focuses on sickle cell disease, chronic leukemia, and myeloproliferative disorders. He is Founder and Chairman of the Oman Hereditary Blood Disorders Association.

Salwa Hindawi

Consultant Haematology & Transfusion Medicine President of Saudi Friends for Thalassaemia & SCA Society

President & Scientific Officer of Saudi Society of Transfusion Medicine & Services, Jeddah

Saudi Arabia

Bio

Prof. Salwa Hindawi is a Consultant in Hematology and Transfusion Medicine and serves as part time consultant with MOH, President and Scientific Officer of the Saudi Society of Transfusion Medicine & Services, Jeddah. She is also President of the Saudi Friends for Thalassemia & Sickle Cell Anemia Society. Dr. Hindawi holds key roles in ISBT, WHO, AABB, CAP, and as member of Editorial board of Vox Sanguinis, contributing globally to blood safety, PBM, hemovigilance, and transfusion medicine standards.

Shehab Fareed

Consultant Hematology

Hamad Medical Corporation - HMC

Qatar

Bio

Dr. Shehab Fareed is a Consultant in Hematology at Hamad Medical Corporation (HMC), Qatar. He completed his MBBS at the University of Gezira, Sudan, followed by residency and hematology fellowship training at HMC. He also received advanced training at the Mayo Clinic and MD Anderson Cancer Center. Board-certified by the Royal College of Physicians and the European Hematology Association, Dr. Fareed is actively involved in clinical care, research, and publications.

Zeyad Al Shaibani

Section Head Hematology and Blood and Bone Marrow Transplant

King Faisal Specialist Hospital

Saudi Arabia

Bio

No Bio Available

Scientific Voices

Abstract submission is now closed.

Thank you for Submitting your abstracts and being part of ICCH 2026.

Oral and poster presentations provide a valuable platform to share your research with a focused and engaged audience, enabling direct feedback, discussion, and collaboration. These formats will help raise your profile within the scientific community, opening doors to future opportunities, and career advancement.

Guidelines for submitting an abstract :

A special criterion for accepting abstracts will be their topic as well as structure, content and degree of innovation. The scientific committee will accept abstracts based on their relevance and quality, structure, content and degree of innovation.

Please note that a maximum of 300 words is permitted. The titles and the names of the authors are excluded from this number and have to be entered separately. Tables should not be included in the abstract body.
Methods section should include type of statistical analysis done if applicable to the study.
Statements like “Results will be discussed” are not acceptable and may lead to a rejection of the abstract.

Abstract Delivery Notification

Authors will be notified about the delivery of their abstract by e-mail immediately. In case you do not receive confirmation within 24 hours, please check your spam folder. In case of no confirmation e-mail,
please contact : ipccconference@meetingmindsexperts.com

Stay informed, prepared, and inspired

500

+

12

+

45

+

40

+

Prof. Mohamed A. Yassin

Abdulhakim Al Rawas

Ahmad Tarawah

Asma Al Olama

Hadi Mohamad

Mona Al Rasheed

Mohamed A. Yassin

Biree Andemariam

Drew Provan

Hanny Al-Samkari

Honar Cherif

Khaled Musallam

Mozah AlMarshoodi

Muna Al Tarshi

Salwa Ibrahim Hindawi

Regional Expertise.

Global Insights.

Real Impact.

Who Should Attend?

Oct 8

Online Registration Open (Early Bird)

Dec 23

Abstract submissions opens (Oral/Poster)

Jan 9

Program Topics Announced

Jan 9

Invited Faculty Announced

Feb 16

Abstract Submission Closes

Feb 26

Early Bird Registration Closes

Feb 27

Standard Registration Opens

Mar 2

Final Program

Mar 2

CME Announcement

Mar 2

Author Notifications (Oral/Poster)

Mar 27

ICCH Goes live

Mar 29

Closing Ceremony

Session highlights at a glance

CME Accreditation

Instructions for Claiming CME Certificates:

Disclosure and Resolution of Personal Conflicts of Interest

Session Attendance Scanning :

Abdulhakim Al Rawas

Abdullah Al Zayed

Abdulrahman Al-Mashdali

Afaf Al Battah

Ahmad Tarawah

Ali Taher

Asma Sultan Al Olama

Awni Alshurfa

Biree Andemariam

Caterina Minniti

David Kuter

Drew Provan

Flora Peyvandi

Gerry Dolan

Hadeel Saleh

Hani Osman

Hanny Al- Samkari

Hind Salama

Honar Cherif

Jaffer Altooq

Jan-Inge Henter

Khaled Musallam

Lan-Lan Smith